home / stock / mck / mck articles


MCK Articles, McKesson Corporation - From 05/07/24

Stock Information

Company Name: McKesson Corporation
Stock Symbol: MCK
Market: NYSE
Website: mckesson.com

Menu

MCK MCK Quote MCK Short MCK News MCK Articles MCK Message Board
Get MCK Alerts

News, Short Squeeze, Breakout and More Instantly...

Investor Optimism Decreases Slightly, But Dow Records Gains For 4th Day | Benzinga

The CNN Money Fear and Greed index showed a slight decline in the overall market sentiment, but the index remained in the “Fear” zone o...

McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report | Benzinga

The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its role in advising majo...

If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.24% on an annualized basis producing an average annual return of 35.36%...

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 10 years by 1.42% on an annualized basis producing an average annual return of 12.31%...

Rite Aid Forges Path To Financial Recovery With Major Settlement: Report | Benzinga

Pharmacy chain Rite Aid Corp (OTC:RADCQ) has reportedly reached a pivotal settlement with its lenders, the U.S. Department of Justic...

$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 22.12% on an annualized basis producing an average annual return of 35.12%...

Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech | Benzinga

In a recent report, global wealth manager UBS identified the sectors likely to drive the next wave of technological innovation and the stocks that ...

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation | Benzinga

The Federal Trade Commission (FTC) is reportedly launching an investigation into recent shortages of chemotherapies, including carboplatin, cisplat...

Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More' | Benzinga

Wednesday, McKesson Corporation (NYSE:MCK) reported that third-quarter 2024 sales of $80.9 billion increased 15%, beating the consen...

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today | Benzinga

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 17.87% on an annualized basis producing an average annual return of 30.54%...

Previous 10 Next 10